Serial Number | 79218221 |
Word Mark | BIODRONE |
Filing Date | Wednesday, August 9, 2017 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, March 14, 2025 |
Registration Number | 5547866 |
Registration Date | Tuesday, August 28, 2018 |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, June 12, 2018 |
Description of Mark | The mark consists of the wording "BIODRONE" in stylized form. |
Goods and Services | Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating ulcers; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for use in urology; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical purposes; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for medical diagnosis; anti-cancer preparations; tumor suppressing agents |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, March 14, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | MDimune Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Party Name | MDimune Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | KR |
Party Name | MDimune Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Event Date | Event Description |
Tuesday, October 17, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, October 12, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Wednesday, November 29, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, April 30, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, April 30, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 30, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 4, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 23, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, May 23, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, May 23, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Friday, June 8, 2018 | NOTIFICATION PROCESSED BY IB |
Tuesday, June 12, 2018 | PUBLISHED FOR OPPOSITION |
Saturday, October 21, 2017 | APPLICATION FILING RECEIPT MAILED |
Thursday, November 9, 2017 | ASSIGNED TO EXAMINER |
Wednesday, November 15, 2017 | NON-FINAL ACTION WRITTEN |
Thursday, November 16, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, November 29, 2017 | REFUSAL PROCESSED BY MPU |
Sunday, December 17, 2017 | REFUSAL PROCESSED BY IB |
Tuesday, June 12, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 28, 2018 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, November 28, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Monday, December 10, 2018 | FINAL DISPOSITION PROCESSED |
Monday, December 10, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
Monday, August 28, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Friday, March 14, 2025 | CANCELLED SECTION 71 |
Friday, September 3, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Friday, December 28, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |